by Devices and Pharma | Mar 31, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
New Treatment for Platinum-Resistant Ovarian Cancer Mirvetuximab Soravtansine-Gynx (Elahere) Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact In a significant...
by Devices and Pharma | Mar 30, 2024 | Alerts, Alerts-Pharma, Consumer Information, Consumer Safety, FDA Safety Communication, Industry News, Pharmaceuticals, Product Recalls, Product Safety, US-FDA
Urgent Recall Alert – Methocarbamol Injection by Eugia US LLC Foreign particles detected in vials Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Attention...
by Devices and Pharma | Mar 30, 2024 | Alerts, Alerts-Pharma, Class I Recalls, Consumer Information, Consumer Safety, FDA Safety Communication, Industry News, MedWatch-System, Pharmaceuticals, Product Recalls, Product Safety
Amneal Recalls Vancomycin Hydrochloride Oral Solution Overfilling may lead to serious overdoses Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Some bottles may be...
by Devices and Pharma | Apr 4, 2023 | Alerts, Alerts-Pharma, Consumer Information, Consumer Safety, FDA Safety Communication, Industry News, Pharmaceuticals, Product Recalls, Product Safety
Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact Camber Recalls Atovaquone Oral Suspension USP for Potential Contamination Camber Pharmaceuticals Inc. recently...
by David McConkey | Mar 19, 2023 | FDA Approvals, FDA Public Information, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug Administration (FDA) on February 17, 2023 announced the approval the first-ever enzyme...
by David McConkey | Mar 16, 2023 | FDA Approvals, FDA Public Information, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
Home About Consumer Regulatory Medical Devices Pharma Biologics Combination Products AI Quality QMSR Central News Enforcement Alerts Innovation Contact The U.S. Food and Drug Administration (FDA) on December 22, 2022 announced the approval of a new HIV drug called...
